Manhattan Bridge Capital, Inc. Reports Second Quarter 2024 Results
GREAT NECK, N.Y., July 22, 2024 (GLOBE NEWSWIRE) — Manhattan Bridge Capital, Inc. (Nasdaq: LOAN) (the “Company”) announced today that its […]
Verizon delivers strong wireless service revenue and broadband subscriber growth in Q2
Company remains on track to meet full-year 2024 financial guidance 2Q 2024 Highlights Wireless: Accelerated growth in wireless service revenue […]
TSX News -
PyroGenesis Announces Closing of a $2.8 Million Non-Brokered Private Placement
NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR DISSEMINATION IN THE U.S. MONTREAL, July 22, 2024 (GLOBE NEWSWIRE) — […]
Xali Gold Enters Agreement for Mining in Historic Underground Workings, Exploration and Reducing Debt at El Oro Mexico
VANCOUVER, British Columbia, July 22, 2024 (GLOBE NEWSWIRE) — Xali Gold Corp. (TSXV:XGC) (“Xali Gold” or “the Company”) is very […]
Perspective Therapeutics to Provide Business Highlights and Report Second Quarter 2024 Financial Results
SEATTLE, July 22, 2024 (GLOBE NEWSWIRE) — Perspective Therapeutics, Inc. (NYSE AMERICAN: CATX), a radiopharmaceutical company that is pioneering advanced […]
Ero Copper and Vale Base Metals Execute Definitive Earn-In Agreement on the Furnas Copper Project
VANCOUVER, British Columbia, July 22, 2024 (GLOBE NEWSWIRE) — Ero Copper Corp. (TSX: ERO, NYSE: ERO) (“Ero” or the “Company”) […]
BioNTech to Report Second Quarter 2024 Financial Results and Corporate Update on August 5, 2024
MAINZ, Germany, July 22, 2024 (GLOBE NEWSWIRE) — BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”) will announce its financial […]
Castellum, Inc. Announces Strategic Alliance with K2
VIENNA, Va., July 22, 2024 (GLOBE NEWSWIRE) — Castellum, Inc. (“Castellum” or the “Company”) (NYSE-American: CTM), a cybersecurity, electronic warfare, […]
Cellectar Biosciences Announces Exercise of Tranche B Warrants and Purchase of New Warrants for Approximately $19.4 million with the Potential to Raise Up to an Additional $73.3 Million
FLORHAM PARK, N.J., July 22, 2024 (GLOBE NEWSWIRE) — Cellectar Biosciences, Inc. (NASDAQ: CLRB), a late-stage clinical biopharmaceutical company focused […]
STADA and Alvotech launch Uzpruvo, the first approved ustekinumab biosimilar to Stelara, across Europe
STADA and Alvotech launch Uzpruvo, the first approved ustekinumab biosimilar to Stelara, across Europe Launch of European-made Uzpruvo in Europe […]
